Loading insider details...
Latest Form 4 (Jun 2, 2026): Grant/Award of 21,335 TSHA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 2, 2026 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 21,335 | n/a |
| Apr 30, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 50,000 | n/a |
| Jun 4, 2025 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 56,623 | n/a |
| Jan 7, 2025 | Intellia Therapeutics, Inc. (NTLA) | Sale | 8,966 | $109.2K |
| Jan 3, 2025 | Intellia Therapeutics, Inc. (NTLA) | Exercise/Conversion | 3,500 | n/a |
| May 31, 2024 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 49,220 | n/a |
| Mar 5, 2024 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 37,966 | n/a |
| Jan 10, 2024 | Intellia Therapeutics, Inc. (NTLA) | Sale | 1,608 | $46.1K |
| Jan 5, 2024 | Intellia Therapeutics, Inc. (NTLA) | Sale | 5,532 | $163.0K |
| Jan 3, 2024 | Intellia Therapeutics, Inc. (NTLA) | Exercise/Conversion | 3,500 | n/a |